Zhaotao Wang

机构：Fujian University of Traditional Chinese Medicine, Fuzhou Second Hospital · ORCID：0000-0001-5049-8626

发表论文 43 篇 · 总被引 962 次 · h-index 18

代表论文

• Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma (2021 · BMC Cancer · 被引 56)
• PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B (2023 · Oncogene · 被引 44)
• A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma (2020 · British Journal of Pharmacology · 被引 39)
• Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT) (2022 · European Journal of Pharmacology · 被引 22)
• LHPP impedes energy metabolism by inducing ubiquitin-mediated degradation of PKM2 in glioblastoma. (2021 · PubMed · 被引 20)
• Clemastine promotes recovery of neural function and suppresses neuronal apoptosis by restoring balance of pro-inflammatory mediators in an experimental model of intracerebral hemorrhage (2020 · International Journal of Medical Sciences · 被引 19)